RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION Read more about RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION US Application 62/748,905Filed on 2018-10-22
HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF Read more about HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF US Application 62/716,169Filed on 2018-08-08
METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT Read more about METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT US Application 62/688,031Filed on 2018-06-21
WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING Read more about WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING US Application 62/721,986Filed on 2018-08-23
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US Application 62/749,750Filed on 2018-10-24
OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) Read more about OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) US Application 62/732,885Filed on 2018-09-18
BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME Read more about BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME US Application 62/697,287Filed on 2018-07-12
CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer Read more about CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US Application 62/452,244Filed on 2017-01-30
Tumor Inflltrating Lymphocytes And Methods Of Therapy Read more about Tumor Inflltrating Lymphocytes And Methods Of Therapy US Application 62/409,651Filed on 2016-10-18
Viral Methods Of T Cell Therapy Read more about Viral Methods Of T Cell Therapy US Application 62/452,081Filed on 2017-01-30